Common variations in CYP2C9 and VKORC1 that affect warfarin dose.
. | . | . | Prevalence, % . | |||
---|---|---|---|---|---|---|
. | Name . | Variation . | Caucasian . | African . | Asian . | Effect on warfarin dose, % . |
† Data approximate from references 13,14,16,17 | ||||||
‡ From reference 12 | ||||||
§From references 12,14 | ||||||
CYP2C9 | ||||||
*1 | Wild-type | 81 | 94 | 98 | Reference | |
*2 | R144C | 13 | 3 | 0 | − 20† | |
*3 | I359L | 7 | 2 | 2 | − 30† | |
VKORC1 | ||||||
Group A | Haplotypes 1,2‡ | 37 | 14 | 89 | −20§ | |
Group B | Haplotypes 7,8,9 | 58 | 49 | 10 | Reference |
. | . | . | Prevalence, % . | |||
---|---|---|---|---|---|---|
. | Name . | Variation . | Caucasian . | African . | Asian . | Effect on warfarin dose, % . |
† Data approximate from references 13,14,16,17 | ||||||
‡ From reference 12 | ||||||
§From references 12,14 | ||||||
CYP2C9 | ||||||
*1 | Wild-type | 81 | 94 | 98 | Reference | |
*2 | R144C | 13 | 3 | 0 | − 20† | |
*3 | I359L | 7 | 2 | 2 | − 30† | |
VKORC1 | ||||||
Group A | Haplotypes 1,2‡ | 37 | 14 | 89 | −20§ | |
Group B | Haplotypes 7,8,9 | 58 | 49 | 10 | Reference |